Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
life sciences
3
×
national
3
×
national blog main
national top stories
alex azar
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
drug pricing
fda
indiana blog main
indiana top stories
medicare
new york blog main
new york top stories
president trump
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
alliance for aging research
amgen
biogen
biotechnology innovation organization
consumer choice center
david clement
department of health and human services
donald trump
What
administration
3
×
trump
3
×
cheaper
drug
plan
angry
announced
anti
awaited
benefited
biopharma
blueprint
canada
canadian
costly
countries
department
despite
drugs
excludes
fear
floats
foreign
health
house
import
industry
long
losing
lowering
medicare
medications
observers
ones
pharma
plans
prescription
presidential
price
prices
Language
unknown
Current search:
administration
×
trump
×
national
×
" life sciences "
×
@xconomy.com
4 years ago
White House Floats Canadian Import Plan But Excludes Many Costly Drugs
@xconomy.com
5 years ago
Losing “Scalps”? Despite Pharma Fear, A Split on Trump Rx-Price Plans
@xconomy.com
5 years ago
Trump Plan Ties Medicare Drug Prices to Cheaper Foreign Ones